Effect of the Alogliptin in hypertensive patients with diabetes using Piogritazon.
Not Applicable
Recruiting
- Conditions
- Hypertensive diabetic patients
- Registration Number
- JPRN-UMIN000007904
- Lead Sponsor
- Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients on therapy of DPP-4i. Informed consent cannot be obtained. Any other condition which the attending physician feels would interfere with the trial participation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method One year after,surrogate marker of arterial sclerosis
- Secondary Outcome Measures
Name Time Method